Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Eisai
Eisai
Trending Articles
Ariceum Therapeutics' radiopharmaceutical SCLC therapeutic receives FDA Orphan Drug Designation
The therapeutic candidate will enter into Phase I/II clinical trials in Q1 of 2025, and has shown significant promise in treating aggressive cancers such as SCLC in preclinical...
Weight loss drugs boost big pharma earnings, says AvaTrade
This week pharmaceutical giants Eli Lilly and Novo Nordisk both released their financial results for the fourth quarter of 2024, showcasing major developments in their obesity...
State-of-the-art vial filling solution offers both flexibility and speed
Syntegon installs the world's fastest filling line with integrated in-process control for IDT Biologika
BioMed X and Merck successfully complete ecDNA oncology research programme
The project looked at which genes impact the prevalence of extrachromosomal DNA in cancer cells, and how ecDNA influences the adaptability of these cells
How is generative AI driving value in the life sciences sector?
Generative AI has the potential to expedite clinical discovery and to streamline timely processes
Upcoming event
Pharma Packaging and Labelling Forum
5–6 March 2025 | Conference | San Diego, US
See all
Related Content
Regulatory
Alzheimer's drug lecanemab deemed unsuitable for the UK NHS by health regulator
The drug will not be available on the NHS owing to significant and potentially life-threatening side effects, as well as the cost of the medicine and its limited efficacy
Regulatory
FDA grants landmark approval for Alzheimer’s treatment
LEQEMBI is the first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer’s disease
Regulatory
AbbVie and Eisai launch online Humira support tool service
The free-of-charge service assists patients on Humira therapy by delivering support tools to their home or other requested location
Finance
Eisai and Fuji Yakuhin sign ASEAN distribution agreement for gout therapy
Hyperuricemia is known to be associated with various diseases in the urinary system, endocrine system, metabolic system, cardio-cerebrovascular system etc., including gout
Research & Development
Eisai and Biogen announce Phase IV Alzheimer's study design
The companies will be evaluating the long-term effectiveness and safety data of Biogen's Alzheimer's therapy, Aduhelm
Regulatory
Eisai and Merck combination cancer therapy approved by FDA
The approval for this population is based on results from a Phase III Study 309/KEYNOTE-775 trial
Research & Development
Eisai makes major investments in drug creation
Platform will be established to combine Eisaid know-how with external big data and genomic data for drug innovation in neurology and oncology
Subscribe now